Re: BIO CEO Slides Up
|
8
|
Resverlogix Corp.
|
Feb 13, 2019 10:21AM
|
Re: BIO CEO Slides Up
|
3
|
Resverlogix Corp.
|
Feb 13, 2019 12:06PM
|
Re: BETonMACE Placebo Estimate
|
5
|
Resverlogix Corp.
|
Feb 20, 2019 12:21PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 01:00PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 01:22PM
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 04:16PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 03:52PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:25PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:28PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:29PM
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:29PM
|
Re: BETonMACE Enrollment
|
2
|
Resverlogix Corp.
|
Feb 22, 2019 08:09PM
|
Re: BETonMACE Enrollment
|
|
Resverlogix Corp.
|
Feb 23, 2019 01:14PM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
2
|
Resverlogix Corp.
|
Feb 12, 2019 11:35AM
|
Re: Any thoughts to why BETonMACE patient median eGFR is so high?
|
1
|
Resverlogix Corp.
|
Feb 12, 2019 09:40AM
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 21, 2019 05:54PM
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 20, 2019 11:48AM
|
Re: ACC 2019 Abstracts
|
1
|
Resverlogix Corp.
|
Mar 21, 2019 11:59AM
|
Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 01, 2018 06:15PM
|
BETonMACE Placebo Estimate
|
10
|
Resverlogix Corp.
|
Feb 19, 2019 05:36PM
|